Roger Adsett, Chief Operating Officer of Insmed Inc. (NASDAQ:INSM), recently sold a substantial amount of company stock. According to an SEC filing, Adsett sold a total of 43,975 shares on February 10 ...
Stifel analysts maintained their Buy rating on Insmed shares (NASDAQ:INSM) and increased the price target from $88.00 to $97.00. According to InvestingPro data, the stock has delivered an impressive ...